Protein Z G79A polymorphism and puerperal cerebral venous thrombosis

Clin Appl Thromb Hemost. 2015 Nov;21(8):768-71. doi: 10.1177/1076029614538491. Epub 2014 Jun 6.

Abstract

Protein Z (PZ), a cofactor for PZ-dependent protease inhibitor, is known to play an important role in inhibiting the coagulation cascade. The aim of the study was to investigate whether PZ G79A polymorphism is a risk factor for puerperal cerebral venous thrombosis (CVT). A total of 71 patients with puerperal CVT and 98 healthy controls were genotyped for PZ 79GA polymorphism by polymerase chain reaction-restriction fragment length polymorphism method. In patients, the genotype distribution for GG, GA, and AA genotypes was 22.5%, 43.7%, and 33.8%, and in controls, 25.5%, 40.8%, and 33.7%, respectively. The risk associated with carrying the mutant genotype (GA and AA) versus the wild GG genotype was found to be 1.11 (95% confidence interval: 0.52-2.35; P = .909). There was no significant difference in the clinical features of the patients with and without the polymorphism. We therefore conclude that PZ G79A polymorphism is not a risk factor for puerperal CVT in Indian women.

Keywords: protein Z; protein Z G79A polymorphism; puerperal cerebral venous thrombosis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Proteins / genetics*
  • Female
  • Humans
  • Indien
  • Intracranial Thrombosis / genetics*
  • Mutation*
  • Polymorphism, Restriction Fragment Length*
  • Puerperal Disorders / genetics*

Substances

  • Blood Proteins
  • plasma protein Z